Publications by authors named "Guillermo Reategui"
Ophthalmology
October 2010
Article Synopsis
- The study analyzed the effects of intravitreal bevacizumab (IVB) on visual acuity and anatomical changes over 24 months in patients with age-related macular degeneration (AMD) related to choroidal neovascularization (CNV).
- A total of 180 patients from nine centers were treated with either 1.25 mg or 2.5 mg doses of IVB, with significant improvements in best-corrected visual acuity (BCVA) observed in both dosage groups throughout the study.
- Although both doses showed positive results, the 2.5 mg group had notable systemic complications, indicating a need for cautious monitoring when using higher dosages.
